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Abstract. Diphtheria toxin belongs to a group of toxic 
proteins that enter the cytosol of animal cells.  We 
have here investigated the effect of NH2-terminal ex- 
tensions of diphtheria toxin on its ability to become 
translocated to the cytosol. DNA fragments encoding 
peptides of 12-30 amino acids were fused by recombi- 
nant  DNA technology to the 5'-end of the gene for a 
mutant toxin. The resulting DNA constructs were trans- 
cribed and translated  in vitro. The translation  products 
were bound to ceils and then exposed to low pH to 
induce translocation across the cell membrane.  Under 
these conditions all of the oligopeptides tested,  includ- 
ing three viral peptides and the leader peptide of diph- 
theria toxin,  were translocated to the cytosol along 
with the enzymatic part (A-fragment) of the toxin.  Nei- 
ther hydrophobic nor highly charged sequences blocked 
translocation.  The results are compatible with a model 
in which the COOH-terminus of the A-fragment first 
crosses the membrane,  whereas the NH2-terminal re- 
gion follows behind.  The possibility of using nontoxic 
variants of diphtheria toxin as vectors to introduce pep- 
tides into the cytosol to elicit MHC class 1-restricted 
immune response and clonal expansion of the relevant 
CD8  ÷ cytotoxic T  lymphocytes is discussed. 
N 
'EWLY synthesized  proteins  are translocated across a 
number of different membranes in cells (Blobel and 
Dobberstein,  1975;  Wickner  and  Lodish,  1985; 
Schatz,  1987; Keegstra,  1989; Neupert et al., 1990). Where- 
as in most cases translocation  occurs from the cytosol into 
organelles,  a number of  bacterial and plant toxins possess the 
ability to  enter  the cytosol from  extracytosolic locations 
(Olsnes  et  al.,  1988a).  Among  these  toxins,  the  uptake 
mechanism has been most extensively studied in the case of 
diphtheria toxin (Olsnes et al.,  1988b).  Membrane translo- 
cation of diphtheria  toxin can be regarded as a simple model 
system to study how a water-soluble protein becomes able 
to cross lipid bilayers. 
Diphtheria  toxin is synthesized as a single chain polypep- 
tide, which is readily cleaved ("nicked") at a trypsin-sensitive 
site to yield two disulfide-linked  fragments,  A and B (Drazin 
et al.,  1971). The B-fragment  (37 kD) binds to cell surface 
receptors  and  facilitates  membrane  translocation  of the 
A-fragment  (21  kD) to the cytosol (Uchida et al.,  1972) 
where it ADP-ribosylates elongation  factor 2 (Honjo et al., 
1968) and thereby inhibits protein synthesis and kills the cell 
(Yamaizumi et al.,  1978).  The insertion  of the B-fragment 
into the cell membrane is understood to some extent (Mos- 
kaug et al.,  1988;  McGill et al.,  1989;  Moskaug et al., 
1991), but little is known about the way the A-fragment tra- 
verses the membrane. In the present work we have investi- 
gated whether the translocation apparatus,  consisting  of the 
B-fragment and probably the toxin receptor (Stenmark et al., 
1988), is specific for the A-fragment  alone,  or if additional 
sequences at the NH2-terminus  of the A-fragment  can be 
translocated. 
Translocation  of the A-fragment  to the cytosol normally 
occurs across the limiting membrane of endosomes (Marnell 
et al., 1984; Sandvig et al., 1984). At the low vesicular pH, 
the B-fragment  exposes hydrophobic  regions (Sandvig  and 
Olsnes,  1981; Blewitt et al.,  1985; Cabiaux et al.,  1989), 
whereas the A-fragment undergoes conformational  changes 
that may make it more translocation competent and thus by- 
pass the need for molecular chaperones (Zhao and London, 
1988; Dumont and Richards,  1988; Cabiaux et al.,  1989). 
When cells with surface-bound toxin are exposed to acidic 
medium, translocation  occurs from the cell surface (Draper 
and Simon,  1980; Sandvig and Olsnes,  1980, 1981). Because 
it enables us to distinguish  between translocated  and non- 
translocated material (Moskaug et al., 1987, 1988), we have 
here used this artificial system to study membrane transloca- 
tion  of A-fragment  with  and without NH2-terminal  exten- 
sions. 
Materials and Methods 
Materials 
Rabbit  rcticulocyte  lysate  (micrococcal  nuclease-treated)  and  RNasin 
ribonuclease inhibitor were from Promega Biotec (Madison, WI). Pronase 
E,  N-ethylmaleimide,  PMSF,  NaE  monensin,  MES  (2[N-morpholino] 
ethanesulfonic acid), trypsin (N-tosyl-L-phenylalanine-treated),  and Triton- 
X-100 were from Sigma Chemical Co. (St. Louis, MO). Na-vanadate was 
from Ventron (Karlsruhe,  Germany). Aprotinin was obtained from Bayer 
(Leverkusen, Germany). Restriction enzymes, T4 DNA polymerase and 
SP6 RNA polymerase were from New England Biolabs (Beverly, MA). T3 
RNA polymerase was obtained from Gibco-BRL (Eggenstein,  Germany). 
Diphtheria toxin was purified from a crude preparation obtained from Con- 
naught Laboratories (Willowdale, Ontario, Canada) as described (Sandvig and 
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activity of 2  x  104 cpm/ng. Anti-B3: The peptide GVDEYNEMPMPV 
was synthesized by Cambridge Research Biochemicals (Cambridge, UK) 
and coupled to keyhole limpet hemocyanin with glutaraldehyde. Rabbits 
were injected six times with 2 wk interval with 200 #g conjugate, and 8 d 
after the last immunization they were bled by heart puncture. Anti-diph- 
theria toxin serum was obtained by injecting rabbits five times at 2 wk inter- 
val with 100/~g diphtheria toxoid. Oligonucleotides were purchased from 
Med-Probe (Oslo, Norway). 
Buffers and Media 
Hepes medium: DMEM where the bicarbonate was replaced by 20 mM 
Hepes, pH 7.4.  PBS:  140 mM NaCI,  10 mM NaH2PO4,  pH 7.4.  MES- 
gluconate-buffer: 140 mM NaC1, 5 mM MES, 5 mM Na-gluconate, pH 4.8. 
Lysis buffer: PBS containing 1% Triton X-100,  10 mM NaF, 0.1 mM Na- 
vanadate, 200 U/ml aprotinin, 1 mM PMSF, and 1 mM N-ethylmaleimide. 
Cell Culture 
Vero cells were kept as monolayers in tissue culture flasks under 5% CO2 
in Eagle's minimal essential medium containing 5 % FBS. 2 d before the ex- 
periments the ceils were seeded into 12-well plates (Costar Corp., Cam- 
bridge, MA) at a density of 105 cells/well. 
Oligonucleotides 
The following linkers were used in the DNA manipulations (restriction sites 
used to check the orientation are indicated): 
B3 linker: 
Sail 
CATGGGCGTCGACGAATATAACGAAATGCCCATGCCTGTGAA 
CCGCAGCTGCTTATATTGCTTTACGGGTACGGACACTTGTAC 
M  linker: 
ApaI  KpnI 
CATGAAAGGTATCC  TAGGGCCCGTCT  TCACGTTAACGGTACC  TAG 
TTTCCATAGOATCCCGGGCAGAAGTGCAATTGCCATGGATCGTAC 
NP linker: 
BspMII 
CATGAGATATTGGGCTATTAGGACGCGTTCCGGAGG 
TCTATAACCCGATAATCCTGCGCAAGGCCTCCGTAC 
A/N linker: 
Sacl  Xhol 
CATGAGCAACGAAAATATGGACGCAATGGAGAGCTCGACACTCGAGCT 
TCGTTGCTTTTATACCTGCGTTACCTCTCGAGCTGTGAGCTCGAGTAC 
Plasmids 
pGD-2, encoding sp-DT:  This plasmid encodes dipththeria toxin-Ser-148 
with its natural signal peptide, (referred to as sp), after an SP6 promoter. 
To create pGD-2, pGD-1  (McGill et al.,  1989) was digested with HindlII 
and PstI, the overhangs were removed with Sl-nuclease, and the plasmid 
was religated. All other plasmids were based on pBND-2 (McGill et al., 
1989),  which encodes DT behind a T3 promoter. The initiator ATG of DT 
is in pBND-2 located in a unique NcoI site. The following plasmids were 
constructed by inserting linkers with NcoI-compatible overhangs into the 
NcoI site of pBND-2. Each linker could be ligated in two orientations, ei- 
ther as written, or in the "reverse" orientation. Three of the linkers were 
used in both orientations, to generate two different sets of NH2-terminal 
extensions. All linkers contain asymmetrically located restrictions sites, 
which where used to confirm the orientation of the linkers. Except in the 
case of pBD-B3-1, the NcoI site was removed by the linker insertions, pBD- 
B3-1, encoding B3-DT: B3 linker (a NcoI site was regenerated at the initia- 
tor ATG). pBD-NP-1,  encoding NP-1-DT: NP linker, pBD-NP-2, encoding 
NP-2-DT: NP linker, reverse, pBD-A/N-1, encoding A/N-1-DT: A/N linker. 
pBD-A/N-2, encoding A/N-2-DT: A/N linker, reverse, pBD-M-1, encoding 
M-1-DT: M linker, pBD-M-2, encoding M-2-DT: M linker, reverse. The fol- 
lowing plasrnids were constructed by inserting the appropriate linkers into 
the NcoI site of pBD-B3-1,  as described above: pBD-NP-B3-I, encoding 
NP-B3-1-DT: NP linker,  pBD-NP-B3-2, encoding NP-B3-2-DT:  NP linker, 
reverse, pBD-A/N-B3-1, encoding A/N-B3-1-DT:  A/N linker,  pBD-A/N- 
B3-2, encoding A/N-B3-2-DT: A/N linker, reverse. E.  coli  strain DH5c~ 
was used as the host bacterium during all cloning manipulations. 
In Vitro Transcription and Translation 
The plasmids were linearized downstream of the toxin gene with EcoRI, 
and transcribed in vitro (Maniatis et al.,  1982),  using SP6 polymerase in 
the case of pGD-2 and T3 polymerase in all other cases. The mRNAs ob- 
tained were translated in rabbit reticulocyte lysate systems in the presence 
of [35S]methionine  (Pelham and Jackson,  1976;  McGill et al.,  1989).  To 
remove reducing agents and unincorporated [35S]methionine,  the transla- 
tion mixture was dialyzed overnight against Hepes medium. 
Translocation Assay 
The translation products were diluted in Hepes medium and added to Vero 
cells growing as monolayers in 12-well microtiter plates and kept at 24°C 
for 20 min in the presence of 10 #M monensin (Moskaug et al., 1988). The 
cells were washed twice with Hepes medium and subsequently treated with 
0.4/zg/ml trypsin in Hepes medium containing 10 #M monensin for 5 min 
at 24°C. The cells were washed and exposed to MES-gluconate buffer, pH 
4.8.  After 2 min at 37°C, the cells were treated with 3 mg/ml pronase E 
in Hepes medium, pH Z4, containing 10 #M monensin for 5 min at 37°C. 
The cells, which were detached from the plastic by the treatment, were recov- 
ered  by centrifugation  and washed  once with Hepes  medium containing 1 mM 
N-ethylmaleimide and  1 mM PMSE  The cell pellets were either treated 
with saponin or lysed in lysis buffer, as described in legends to the figures. 
SDS-PAGE 
Electrophoresis was carried out in discontinuous gels (13.5 % acrylamide in 
the separating gel) in the presence of SDS as described (Laemmli, 1970). 
The gels were fixed in 4% acetic acid/27% methanol for 30 min, and then 
treated with 1 M Na-salicylate, pH 5.8, in 2% glycerol for 30 min. Subse- 
quently, the gels were dried and placed on Kodak XAR-5 films in the ab- 
sence of intensifying screens at  -80°C for fluorography. 
Immunoprecipitation 
Aliquots of 20/zl protein A-Sepharose (Pharmacia, Uppsala, Sweden) were 
incubated with 0.5 #1 of the appropriate antiserum for 30 min at ambient 
temperature, and then washed twice with lysis buffer. 200-/~1 samples of cell 
lysate or diluted translation products were then added and kept at 4°C for 
60 rain with rotation. The pellets were subsequently washed three times 
with lysis buffer and once with water, and finally subjected to SDS-PAGE. 
Results 
Membrane Translocation of  A-fragment with 
a 14-Amino Acid NHrterminal Extension 
Cloning of wild-type diphtheria toxin is considered hazard- 
ous, and the mutant proteins studied here are based on the 
diphtheria toxin mutant DT (previously referred  to as A-58 
[McGill et al., 1989]). DT is identical to wild-type toxin, ex- 
cept that Glyl is replaced by methionine to ensure in vitro 
translational initiation, and that Glu148, which is located in 
the active site, is substituted by serine. The serine substitu- 
tion reduces  the toxicity  '~800-fold  compared  with  wild- 
type toxin (Barbieri and Collier,  1987). 
To study whether an extension of diphtheria toxin A-frag- 
ment would be tolerated with respect to translocation, we 
fused the 14-mer peptide B3, which we had raised an anti- 
serum against, to the NH2-terminal end of DT (see Fig.  1). 
The data in Fig. 2 A show that in vitro translated fusion pro- 
tein (lane/) migrated slightly slower in the gel than DT (lane 
2). The fusion protein was precipitated with anti-B3 (lane 4), 
but not with a control antiserum (anti-ricin, lane 5). DT was 
not immunoprecipitated with anti-B3  (lane 3). 
To  compare  the  translocation  competence  of the  NH2- 
terminally modified toxin with that of DT, we bound the ra- 
diolabeled toxins to Veto cells, nicked cell-bound toxin with 
trypsin and then exposed the cells briefly to acidic (pH 4.8) 
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sions.  The diphtheria toxin mutant DT (535  residues)  is identical 
to wild-type diphtheria  toxin,  except  that  Glyl  was  replaced  by 
methionine  and Glu~4s by serine (numbering of amino acids refers 
to the diphtheria  toxin sequence as published by Greenfield  et al. 
(1983).  The A-fragment  is  represented  by an open box,  and the 
B-fragment by a filled box. The site of interfragment trypsin cleav- 
age is indicated.  The position of the peptide  fusions is indicated by 
a hatched box. Amino acid sequences of  the different fused peptides 
are shown in the single-letter  code.  Basic  amino acids (Arg,  Lys, 
and His) are marked with +  and acidic residues (Glu and Asp) with 
-. B3 is a peptide  corresponding to the COOH-terminal end of a 
band 3-like protein (Demuth et al., 1986) with the additions of  initi- 
ator methionine and a terminal  asparagine for cloning purposes. 
M-1 is an immunogenic peptide from the matrix protein of influenza 
A virus, strain A/NT/60/68 (Gotch et al.,  1987). A/N-1 and NP-I 
are immunogenic peptides from the nucleoprotein of  the same virus 
(Townsend et al.,  1985).  M-2, A/N-2, and NP-2 are encoded by 
reverse  linkers  for A/N-I, NP-1, and M-l,  respectively.  NP-B3-1, 
NP-B3-2,  A/N-B3-1,  and  A/N-B3-2 are  fusions  of NP-1, NP-2, 
A/N-l,  and  A/N-2,  respectively,  with  B3.  SP, signal  peptide  of 
diphtheria  toxin. 
medium.  Nontranslocated  material  was  subsequently  re- 
moved by pronase digestion.  The cells were finally assayed 
for the presence of pronase-protected radiolabeled material. 
To inhibit translocation from acidic vesicles, monensin was 
present  during  all  incubations,  except during the brief low 
pH pulse. 
As found earlier  (Moskaug et al.,  1988),  full-length DT 
gave rise to two protease-protected polypeptides of 25 and 
21 kD (Fig. 2 B, lane/).  The 25-kD polypeptide represents 
the  COOH-terminal  ~230  residues  of  the  B-fragment 
(Moskaug et al.,  1991), whereas the 21-kD band represents 
the A-fragment (Moskaug et al.,  1988). Since electrophore- 
sis  was  carried  out  under  nonreducing  conditions,  cell- 
Figure 2.  DT with NH2-terminally  fused B3 oligopeptide.  (A) In 
vitro translation  and immunoprecipitation.  Aliquots  (1  #1) of in 
vitro translated,  [35S]methionine-labeled  DT (lanes  2 and 3) and 
B3-DT  (lanes  1,  4,  and 5)  were analyzed by SDS-PAGE,  either 
directly or after immunoprecipitation with anti-B3 or anti-ricin,  as 
indicated.  Fluorography was for 16 h. The arrows indicate  the gel 
migration of size markers.  (B) Translocation  to the cytosol. DT and 
B3-DT (~1  nM)  were added to Vero cells,  translocation  was in- 
duced by low pH and the cells were treated  with  pronase as de- 
scribed  in Materials  and Methods.  In some cases (lanes  1-3 and 
8-10),  the cells were then dissolved  with lysis buffer, nuclei were 
removed by centrifugation,  and the protein in the supematant frac- 
tion was precipitated  with 5 % TCA (total  extract)  or immunopre- 
cipitated  with anti-B3 or preimmune serum. In other cases (lanes 
4-7) the cells were treated with 50 #g/ml saponin in PBS containing 
1 mM N-ethylmaleimide  and 1 mM PMSF to release translocated 
A-fragment,  and then the proteins both in the pellet and in the su- 
pernatant fractions were precipitated  with TCA.  In all  cases the 
precipitated  material was analyzed by SDS-PAGE under nonreduc- 
ing conditions.  Fluorography was for 6 d. 
mediated  reduction  of the  interfragment  disulfide  bridge 
must have  taken place.  Conceivably,  the  reduction  occurs 
upon exposure of the disulfide to the reducing cytosol (Mos- 
kaug et al.,  1987). The interfragment disulfide bridge arises 
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not observe any protease protection of this part of the mole- 
cules. This is probably because only a very small part of the 
NH2-terminal  region  of the  B-fragment is  membrane  in- 
serted, and it may therefore by difficult to detect (Moskaug 
et al.,  1991). 
Pronase protection experiments with DT containing the 
B3 extension (B3-DT) show that two major fragments (25 
and 23 kD) were protected in addition to small amounts of 
21 kD fragment (Fig. 2 B, lane 2). The latter material proba- 
bly represents A-fragments where the translation was initi- 
ated downstream of the first ATG (the ATG at the start of the 
A-fragment is in an optimal initiation context), in accordance 
with the scanning ribosome model (Kozak, 1989). When the 
exposure to low pH was omitted,  no fragments were pro- 
tected (lane 3). The 23-kD fragment, which corresponds in 
size to the A-fragment with attached peptide, was precipi- 
tated by anti-B3 (lane 9),  but not with preimmune serum 
(lane  10). Protected A-fragment without the  oligopeptide 
was not precipitated with anti-B3 (lane 8). The apparently 
larger  amount  of protected  B3-A-fragment  (lane  2)  than 
A-fragment alone (lane/) is due to more radioactivity incor- 
porated, as the former contains 8 methionines, whereas the 
latter contains 5. 
When cells with translocated diphtheria toxin are treated 
with a low concentration of saponin, allowing cytoplasmic 
marker enzymes to leak out of the cells without dissolving 
the membranes, the translocated A-fragment is released into 
the medium whereas the B-fragment-derived 25-kD poly- 
peptide remains associated with the membrane fraction (Mos- 
kaug  et al.,  1988).  This indicates  that  the A-fragment is 
translocated to the cytosol, whereas the 25-kD polypeptide 
is inserted into the membrane. Also most of the B3-A-frag- 
ment was released with saponin (Fig. 2 B, lane 7) in the same 
way as normal A-fragment (lane 6), whereas the 25-kD frag- 
ment was  associated with the membranes (lanes 4 and 5). 
Therefore, it appears that most of the translocated A-frag- 
ment with B3 peptide is, like natural A-fragment, free in the 
cytosol. 
Binding and Trypsin Susceptibility  of  DT with 
Different NHrterminal Extensions 
To investigate whether diphtheria toxin can be used for pep- 
tide translocation in general, or whether only certain types 
of peptides can be translocated, we fused to the A-fragment 
a  number  of peptides  with  different charge,  length,  and 
hydrophobicity (Fig.  1). The translation products, analyzed 
by SDS-PAGE and fluorography, are shown in Fig. 3 A. Oc- 
casionally, contamination with unidentified proteins of  lower 
molecular  weight  was  observed (lane  4).  These proteins 
probably represent molecules translated from prematurely 
Figure 3. Binding and nicking of 
DT with various NH2-terminal  ex- 
tensions. (A) SDS-PAGE  of  trans- 
lated  proteins.  1 /~1  125I-labeled 
diphtheria toxin (lane 1 ) or in vi- 
tro translated, 35S-labeled  mutant 
proteins containing the NH2-ter- 
minal extensions indicated (lanes 
2-12) were  analyzed  by  SDS- 
PAGE under reducing conditions. 
Fluorography was for 12 h.  (B) 
Binding to cells and trypsin sensi- 
tivity. Vero cells were incubated 
with  100  /~1  of Hepes  medium 
containing  ~25I-labeled natural 
diphtheria toxin (lane 1 ) or 35S-la- 
beled in vitro translated DT with 
NH2-terminal  extensions (lanes 
2-12) and binding was allowed to 
occur for 20 min at 24°C. The 
cells were then washed 4 times, 
and incubated  with 0.4 ttg/ml tryp- 
sin for 5 min at 24°C. The cells 
were subsequently washed three 
times with cold PBS and dissolved 
in 200 tzl lysis buffer; nuclei were 
removed by centrifugation.  Pro- 
teins were precipitated with TCA 
and analyzed  by SDS-PAGE  under 
reducing conditions, followed by 
fluorography. The exposure time 
was 3 d. 
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the low molecular weight material does not bind to cells 
(data not shown). 
Unnicked  diphtheria toxin is  translocation incompetent 
(Sandvig and Olsnes, 1981; Moskaug et al., 1988). However, 
several of the  fused peptides  contain  arginine  and  lysine 
residues  and  might be degraded by the trypsin treatment 
necessary to nick the toxin. To test this, we bound the differ- 
ent fusion proteins to Vero cells and added a low concentra- 
tion of trypsin. The nicked, cell-bound proteins were then 
analyzed by SDS-PAGE under reducing conditions. 
As  shown  in  Fig.  3  B,  the  trypsin  concentration  was 
sufficiently high to partially nick cell-bound natural toxin 
(lane/). The faint bands between A- and the B-fragment pre- 
sumably represent partially degraded B-fragment. Like nat- 
ural  toxin,  all  the different fusion proteins were partially 
nicked (lanes 2-12).  Whereas the B-fragment obtained af- 
ter nicking had as expected the same molecular weight in 
all  cases,  the  apparent  molecular weight  of the  obtained 
A-fragments varied depending on the nature of the attached 
peptides. 
It should be noted that the electrophoretic migration rate 
of the A-fragment constructs was not only influenced by the 
size of the attached peptide, but also by its charge. Most re- 
markably, A-fragment fused with the highly acidic 16-mer 
A/N-1 peptide (lane 4) showed a significantly higher migra- 
tion rate than when fused with the 14-mer basic peptide M-1 
(lane 2). When the amount of bound material (B) is com- 
pared with 1 #l of the toxin solution added to the cells (A), 
it appears that DT fused with A/N-B3-1 (lane 9), which con- 
tains as much as seven acidic residues, binds less well than 
the other constructs.  This was confirmed by other experi- 
ments (data not shown). 
In  several cases,  the attached peptide was  partially de- 
graded by the trypsin treatment. Degradation was most pro- 
nounced in the case of NP-B3-1  (lane 1/), which is a fusion 
between a basic peptide, NP-1, and the B3 peptide. Appar- 
ently, the arginines in NP-1 were highly trypsin susceptible 
when placed in front of  B3-DT (lane 1/), but not when placed 
in front of DT alone (lane 3). Similar results were obtained 
when the constructs were treated with trypsin without being 
bound to cells (data not shown). The observed degradation 
must therefore be caused by the trypsin treatment, and not 
by cellbound proteases. 
In some cases, contaminating A-fragments, probably trans- 
lated due to initiation downstream of the first ATG, were ob- 
served. For instance, A/N-2-A-fragment was contaminated 
with  natural-length  A-fragment (lane  7),  which  could be 
explained by translational initiation at Metl  of the natural 
A-fragment in this construct. (Neither the A/N-2 peptide nor 
the NH2-terminus of the A-fragment contain trypsin-suscep- 
tible arginines or lysines.) Similarly, A/N-B3-2-A-fragment 
was contaminated with B3-A-fragment, also probably due to 
downstream initiation. Despite the problems with degrada- 
tion and downstream initiation products, we found that in all 
cases sufficient amounts of the correctly extended A-frag- 
ments were formed to carry out translocation experiments. 
Membrane Translocation of  A-fragment with 
Attached Peptides of Different Charge 
The translocation competence of A-fragment containing the 
various extensions was assayed by pronase protection experi- 
ments. To distinguish between translocated, extended A-frag- 
ment  and  the 25-kD  B-fragment-derived polypeptide,  we 
immunoprecipitated pronase-protected material with an anti- 
diphtheria toxin serum that recognizes the A-fragment, but 
not the 25-kD polypeptide. That the A-fragment, but not the 
25-kD polypeptide, is precipitated by this antiserum is evi- 
dent from Fig. 4, lanes I  and 2, which show total protected 
material and immunoprecipitated material, respectively. 
The results in Fig. 2 B indicated that the B3 peptide; which 
contains three acidic residues, was efficiently translocated. 
We also examined the translocation competence of A-frag- 
ment containing two other, unrelated acidic peptides, A/N-1 
(Fig. 4, lanes 7 and 8) and A/N-2 (lanes (13 and 14). These 
16-mer peptides contain, respectively, 4 and 1 acidic residues. 
In both cases, fragments corresponding in size to A-fragment 
with extensions were protected against pronase and immuno- 
precipitated after low pH exposure (lanes 8 and 14), but not 
when low pH was  omitted (lanes  7 and 13). 
Figure 4. Membrane translocation of DT containing NH~-terminal  peptides with different properties. ~25I-labeled  natural diphtheria toxin 
(lanes 1 and 2) and 35S-labeled, in vitro translated DT with the indicated NH2-terminal extensions (lanes 3-24) were bound tO cells and, 
where indicated, membrane translocation was induced by low pH. After pronase treatment, the cells were lysed in lysis buffer and nuclei 
were removed by centrifugation. Proteins in the supematant fraction were either precipitated with TCA (lane 1 ) or immunoprecipitated 
with antiserum that recognizes the A-fragment but not the 25-kD fragment (lanes 2-16) or with anti-B3 serum (lanes 17-24). The precipi- 
tated proteins were analyzed by SDS-PAGE under nonreducing conditions, followed by fluorography. The exposure time was 10 d. 
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acids have been found to interfere with membrane transloca- 
tion (von Heijne,  1986;  Li et al.,  1988;  Nilsson and von 
Heijne, 1990; Boyd and Beckwith, 1990).  We therefore ex- 
amined the ability of three basic peptides, M-1 (Fig. 4, lanes 
3 and 4), NP-1 (lanes 5 and 6) and M-2 (lanes 9 and 10), con- 
taining respectively one, three, and two basic residues, to be 
translocated together with the A-fragment. As indicated by 
the results in lanes 4, 6, and 10, all three peptides were trans- 
located together with the A-fragment, suggesting that the net 
charge of  the attached peptide does not to a significant extent 
influence the membrane translocation of the A-fragment. 
Consistent with this, also NP-2, a peptide containing one ba- 
sic and one acidic residue was efficiently translocated at low 
pH (lanes 11 and 12). 
Effect of  Peptide Length on Diphtheria 
Toxin-aided Translocation 
The results in Fig. 4,  lanes 3-14 indicated that peptides of 
12-16  residues were efficiently translocated when attached 
to  the  NHrterminus  of diphtheria  toxin  A-fragment.  To 
study whether longer peptides (26-30 residues) can be trans- 
located, we tested the translocation competence of  B3-A-frag- 
ment fused with NP-1, NP-2,  A/N-1  and A/N-2,  yielding 
A-fragment  with the extensions NP-B3-1, NP-B3-2, A/N-B3-1 
and A/N-B3-2, respectively (see Fig.  1). Pronase-protected 
polypeptides were immunoprecipitated with anti-B3 serum. 
The results in Fig. 4, lanes 17-24 indicate that all 4 pep- 
tides were translocated upon exposure to low pH. In the cases 
of NP-B3-2  (lane 20), A/N-B3-1  (lane 22), and A/N-B3-2 
(lane 24), two pronase-protected polypeptides were immu- 
noprecipitated with anti-B3 serum after low pH exposure. 
The upper bands correspond to A-fragment with full-length 
(26 or 30  residues) peptide extension,  whereas the lower 
bands conceivably represent degraded material or B3-A-frag- 
ment, formed by downstream initiation. When we compare 
the relative intensities of the upper and lower band with the 
A-fragments obtained after nicking (compare Fig. 4, lanes 
20, 22, and 24 with Fig. 3 B, lanes 10, 11, and 12, respec- 
tively), it appears that the larger and the smaller A-fragments 
were translocated with approximately the same efficiency. 
This result is promising, since it suggests that even longer 
peptides could be translocated to the cytosol together with 
the A-fragment. However, our efforts to demonstrate this have 
so far been hampered by the trypsin susceptibility and reduced 
receptor affinity of longer constructs (data not shown). 
Membrane Translocation of  A-fragment Containing 
the Diphtheria Toxin Signal Peptide 
To test if a hydrophobic peptide could be translocated with 
the A-fragment, we chose the natural signal peptide (sp) of 
diphtheria toxin, which consists of 25 residues (Fig. 1). Like 
other signal peptides (von Heijne, 1988), it contains a highly 
hydrophobic core region. Fig. 4, lane 15, shows that no part 
of the protein was pronase protected and immunoprecipi- 
tated when low pH incubation of  the cells was omitted. How- 
ever,  when .the cells  were  exposed to  low pH  before the 
pronase treatment, a  polypeptide corresponding in size to 
A-fragment with attached signal peptide was pronase-pro- 
tected and immunoprecipitated (lane 16, top band). Also a 
degradation product (bottom band) was translocated (corn- 
Figure 5. Saponin fractionation of cells with translocated A-frag- 
ment with and without NH2-terminal extensions. 3~S-labeled mu- 
tant toxins containing the extensions indicated (lanes 1-6) and 
m25I-labeled natural diphtheria toxin (lanes 7 and 8) were bound to 
Vero cells and translocation was induced by low pH. The cells were 
then treated with pronase as described, and saponin was added to 
the pelleted cells, as described in the legend to Fig. 2. After saponin 
treatment, proteins in the supernatant fraction (S) and in the pellet 
(P) were analyzed by SDS-PAGE under nonreducing  conditions, as 
described in legend to Fig. 2. Fluorography was for 7 d. 
pare with Fig. 3 B, lane 8). The results indicate that even the 
hydrophobic signal peptide of diphtheria toxin can be trans- 
located across the Vero cell plasma membrane. 
Saponin Fractionation  of Translocated 
Extended A-fragments 
The possibility existed that some of the peptide extensions 
were stuck in the membrane upon translocation. To study if 
A-fragment  containing  various  NH~-terminal  extensions 
were membrane-associated, we used the saponin fractiona- 
tion assay described in Fig. 2 B. The results obtained with 
some of  the constructs are shown in Fig. 5. They indicate that 
A-fragments extended with A/N-B3-2, NP-B3-1, and NP-B3- 
2 were all released into the saponin supernatant (lanes 1, 3, 
and 5), in the same way as natural A-fragment (lane 7). Simi- 
lar results were obtained with the other constructs tested, in- 
cluding the hydrophobic signal poptide (data not shown). As 
expected, the membrane-associated 25-kD B-fragment-de- 
rived polypeptide, was recovered from the pellet fraction in 
all cases (lanes 2, 4,  6, and 8).  The low amount of 25-kD 
polypeptide in lane 2 compared with the amount of protected 
extended A-fragment in lane 1 is probably due to inefficient 
pronase digestion. The data indicate that even extensions of 
30  residues  are completely translocated into the  cytosol, 
without being arrested in the membrane. 
Discussion 
In this  work,  evidence is presented  that diphtheria toxin 
A-fragment can be extended at its NH2 terminus, without 
loss  of translocation  competence.  The  NH2  terminus  is 
probably not involved in initiating the translocation process. 
This would be different from proteins destined for mitochon- 
dria, chloroplasts, and the ER, where NH2-terminal leader 
peptides are crucial for membrane translocation (von Heijne, 
1988). 
The possibility that the protected extended A-fragments 
contained material from the B-fragment rather than the NH2- 
terminally fused peptides is unlikely for several reasons: (a) 
The electrophoretic migration rate of  the protected fragments 
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ter chemical reduction. (b) In several cases the protected frag- 
ments were immunoprecipitated with antibodies against the 
N-terminal extensions. (c) In those cases where it has been 
tested we found that part of the bound toxin with NH2-termi- 
nal extensions was reduced by the cells upon exposure to low 
pH (data not shown), as earlier found  with natural toxin (Mos- 
kaug et al., 1987). It should also be noted that the cells were 
treated with N-ethylmaleimide before lysis or saponin treat- 
ment to exclude the possibility of reduction taking place after 
opening of the cells. We therefore feel that peptides fused to 
the NH2-terminal end of the A-fragment are indeed translo- 
cated to the cytosol. 
Since a number ofpeptides differing in size, charge, and hy- 
drophobicity were found to translocate along with the tox- 
in A-fragment, the translocation apparatus confined by the 
B-fragment/receptor is not restricted to the A-fragment as 
such, but accepts considerable NH2-terminal variation. So 
far we have only demonstrated translocation of  comparatively 
small extra sequences (10-30 residues), but work is in prog- 
ress to study if longer peptides and whole proteins can be 
translocated along with the A-fragment. 
Chaudhary et al. (1990) found that additional peptide mate- 
rial could be added close to the COOH-terminal end of  Pseud- 
omonas exotoxin A without reducing its toxic effect. Possibly 
the additional peptide follows the enzymatically active do- 
main III into the cytosol. However, since the additional pep- 
tide material was introduced outside (behind) the ADP-ribo- 
sylating region of the toxin, it cannot be excluded from the 
presented data that it was trimmed offbefore  membrane trans- 
location. 
The finding that mutant diphtheria toxin of  low toxicity can 
deliver foreign oligopeptides into the cytosol makes it an in- 
teresting tool in experimental biology, in cases where rapid 
and synchronized introduction of specific peptide sequences 
into ceils is required. The intracellular concentration  oftrans- 
located material obtained is low (the maximal intracellular 
concentration  ofA-fragment  obtainedinVero  cells is,~,2 riM), 
but it could still be sufficient for certain purposes, such as 
tracing the intracellular fate of radiolabeled sequences, or in- 
troducing regulatory proteins. 
At present we are interested in exploring the possibility of 
using the toxin-induced peptide translocation in vaccine de- 
velopment. Antigen presentation by major histocompatibil- 
ity antigens (MHC) of class I requires that the antigen to be 
presented is found in the cytosol or in the ER (Townsend et 
al., 1985; Moore et al., 1988; Townsend and Bodmer, 1989; 
Yewdell and Bennink, 1990). Externally added polypeptides 
therefore do normally not elicit a class I response. On the 
other hand, if  the antigen is artificially introduced into the cy- 
tosol, presentation by MHC class I may occur (Moore et al., 
1988;  Yewdell et al.,  1988).  Convenient and nondamaging 
methods to introduce foreign peptides, such as viral antigens, 
into the cytosol could therefore be useful for vaccine purposes 
to expand the relevant population of CD8  ÷ MHC class I-re- 
stricted cytotoxic T-lymphocytes. 
Most human tissues possess receptors for diphtheria toxin, 
and it is likely that toxin with fused oligopeptides would be 
endocytosed by most cells, with subsequent translocation to 
the cytosol. If the oligopeptide used were a viral peptide, it 
might  be presented at the surface, with resulting clonal expan- 
sion of the relevant CD8 ÷ cytotoxic T lymphocytes. In fact, 
three of  the peptides tested in this study, NP-1, M-l, and A/N-1 
(Fig.  1), are (except for the NH2-terminal Met residue) in- 
fluenza virus peptides known to be  presented by defined 
MHC class I allotypes and to elicit cytotoxic T-cell response 
(Townsend et al., 1985; Gotch et al., 1987). Work is now in 
progress to study if the peptides are also presented by class 
I molecules when they are introduced into cells by aid of  diph- 
theria toxin. 
The diphtheria toxin gene used here encodes a  protein 
with a slight residual toxicity (1/800 of wild-type) (Barbieri 
and Collier, 1987),  but we are now trying to prepare com- 
pletely nontoxic mutants which are translocation competent 
and which could safely be used for vaccination. The possibil- 
ity should also be considered that enzymatically  inactive mu- 
tants of other protein toxins that enter the cytosol, such as 
abrin, ricin, Shigella toxin, and cholera toxin (Olsnes and 
Sandvig,  1985) could be used as vectors for peptides. 
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